Profiel
Lynette Hopkinson worked as the VP & Head-Cystic Fibrosis Regulatory Strategy at Vertex Pharmaceuticals, Inc. from 2014 to 2020.
She then worked as the Senior Vice President-Regulatory at Imara, Inc. from 2020 to 2021.
Prior to her career, she completed her undergraduate degree at the University of the Witwatersrand.
Eerdere bekende functies van Lynette Hopkinson
| Bedrijven | Functie | Einde |
|---|---|---|
| VERTEX PHARMACEUTICALS INCORPORATED | Algemeen Adviseur | 01-09-2020 |
| IMARA | Algemeen Adviseur | - |
Opleiding van Lynette Hopkinson
| University of the Witwatersrand | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| VERTEX PHARMACEUTICALS INCORPORATED | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Imara, Inc.
 Imara, Inc. Pharmaceuticals: MajorHealth Technology Imara, Inc. is a biopharmaceutical company, which engages in the development and commercialization of novel therapeutics to treat patients suffering from hemoglobinopathies. The company was founded by James Gregg McArthur in 2016 and is headquartered in Brookline, MA. | Health Technology |
